儿科急性呼吸窘迫综合征中撤机路径与机械通气天数减少相关
该研究为前瞻性儿科ARDS(柏林定义)队列的二次分析,采用中断时间序列分析,比较2016年5月撤机路径实施前后PICU幸存者的有创通气时长和PICU住院时长。共纳入585例存活至PICU出院且通气≤100天的患儿(路径前375例,路径后210例)。控制时间趋势后,路径实施与中位通气天数减少3.6天(95%CI -5.4至-1.7;P<0.001)相关,再插管率无变化。结果在多项敏感性分析中稳健。
要点
- 在儿科ARDS幸存者中,撤机路径实施与中位有创通气天数减少3.6天(95%CI -5.4至-1.7;P<0.001)相关。
- 路径实施前后再插管率无变化,提示缩短通气未以增加再插管为代价。
- 路径采纳迅速且持续,效应量可与ARDS试验中干预目标相比。
- 研究排除PICU死亡患者及有创通气>100天者,结果仅适用于存活至PICU出院的患儿。
- 路径前组更年轻、感染性ARDS更多、替代通气模式使用更多,分析已控制时间趋势并做敏感性分析。
适用人群与场景
- 儿科ARDS(柏林定义)存活至PICU出院且侵入性机械通气≤100天的患儿。
- 排除PICU死亡患者及有创通气>100天者。
- 场景为大型学术三级PICU。
诊断标准与关键阈值
- 儿科ARDS采用柏林定义。
- 原文未提及撤机路径的具体启动/停止阈值或评分界值。
处置流程与药物剂量
- 原文未提及撤机路径的具体步骤、药物剂量或目标值。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:前瞻性儿科ARDS队列的二次分析,采用中断时间序列分析比较撤机路径实施前后。
- 样本量与中心数:单中心,723例儿科ARDS中排除死亡132例及通气>100天6例,纳入585例(路径前375例,路径后210例)。
- 干预与对照:2016年5月实施撤机路径 vs 实施前。
- 主要终点结果:路径实施与中位通气天数减少3.6天相关(95%CI -5.4至-1.7;P<0.001)。
- 关键次要终点:再插管率无变化;结果对多项敏感性分析稳健。
- 不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:单中心前瞻性队列的二次分析(中断时间序列分析)。
- 证据等级或推荐强度:原文未提及。
- 局限:单中心、观察性设计、路径前组基线特征有差异(更年轻、感染性ARDS更多、替代通气模式使用更多),可能存在残余混杂。
对床旁实践的改变
- 在儿科ARDS幸存者中,实施撤机路径可能缩短有创通气时长,且未增加再插管率。
- 该结果不适用于PICU死亡患者或有创通气>100天者。
- 原文未提供路径具体内容,不能据此推断具体撤机步骤或药物方案。
指南或共识出处
- Crit Care Med
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: There is limited evidence on the impact of protocolized ventilator weaning in pediatric acute respiratory distress syndrome, despite utilization in clinical trials and clinical care. We aimed to determine whether protocolized ventilator weaning shortens mechanical ventilation duration and PICU length of stay in pediatric acute respiratory distress syndrome survivors.
DESIGN: Secondary analysis of a prospective pediatric acute respiratory distress syndrome (Berlin definition) cohort from July 2011 to June 2019 analyzed using interrupted time series analysis pre- and postimplementations of a ventilator-weaning pathway. We compared duration of invasive ventilation and PICU length of stay in survivors before and after implementation of a ventilator-weaning pathway. We excluded PICU nonsurvivors and subjects with greater than 100 ventilator days.
SETTING: Large academic tertiary-care PICU.
PATIENTS: Children with acute respiratory distress syndrome who survived to PICU discharge with less than or equal to 100 days of invasive mechanical ventilation.
INTERVENTIONS: Implementation of a ventilator-weaning pathway on May 2016.
MEASUREMENTS AND MAIN RESULTS: Of 723 children with acute respiratory distress syndrome, 132 subjects died and six subjects with ventilation greater than 100 days were excluded. Of the remaining 585 subjects, 375 subjects had acute respiratory distress syndrome prior to pathway intervention and 210 after. Patients in the preintervention epoch were younger, more likely to have infectious acute respiratory distress syndrome, and had increased use of alternative ventilator modes. Pathway adoption was rapid and sustained. Controlling for temporality, pathway implementation was associated with a decrease of a median 3.6 ventilator days (95% CI, -5.4 to -1.7; p < 0.001). There was no change in the reintubation rates. Results were robust to multiple sensitivity analyses adjusting for confounders.
CONCLUSIONS: Ventilator-weaning pathway implementation shortened invasive ventilation duration in pediatric acute respiratory distress syndrome survivors with no change in reintubation. The effect size of this intervention was comparable with those targeted in acute respiratory distress syndrome trials.
参考来源
- Mehta SD, Martin K, McGowan N, et al. Ventilator-Weaning Pathway Associated With Decreased Ventilator Days in Pediatric Acute Respiratory Distress Syndrome. Crit Care Med. 2021. PMID: 33156123. doi:10.1097/CCM.0000000000004704
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。